THIRUVANANTHAPURAM: Social activists in Jharkhand, Bihar and Rajasthan secured a landmark victory in the High Court. They argued that doctors were not adhering to the directive to prescribe generic names of medicines causing distress to patients.

Despite a National Medical Commission directive issued six months ago, most doctors continue to prescribe brand names instead of generic ones. This has led to shortages at hospital pharmacies leaving patients in prolonged queues without access to necessary medications.

The reluctance of doctors to follow the generic prescription mandate has raised concerns about their alleged collusion with pharmaceutical companies. Reports suggest a significant drug trade worth 15,000 crores per year in certain states influencing doctors to favour brand names for personal gains.

According to Dr T N Suresh Kumar, President of KGMOA, doctors in government hospitals tend to favour brand drugs overlooking the prescription of generic alternatives.

The court order emphasizes the importance of prescribing generic names which typically encompass chemical compositions ensuring accessibility and affordability for all. It highlights that most medicines have three names - the chemical, the generic and the brand name with patents held for 20 years.

However, a faction of doctors raises concerns about the quality of generic drugs entering the market. They urge government intervention to regulate and ensure the absence of substandard medications, asserting the need for a reliable drug market.

This directive aims to improve healthcare accessibility and affordability, especially in regions like Kerala, where 10% of India's medicines are sold due to robust medical facilities and heightened health awareness particularly among the elderly grappling with numerous health issues.